Campylobacter in poultry threatens food safety, while farmers need alternatives to antibiotics that do not reduce broiler performance.
R&D Focus
Bacillus subtilis poultry probiotics, pathogen control and feed conversion.
Innovative Solution
A selected Bacillus subtilis PS-216 strain is used as a probiotic feed supplement to suppress Campylobacter and support broiler health and performance.
Solution Effectiveness
A company-reported in-vivo challenge study found a 96% reduction of Campylobacter in the cecum. A 2025 peer-reviewed broiler study reported benefits across performance, gut health and meat-quality measures.
Investment Funding
Last Funding Stage
Pre-Seed
Total Funding Amount
59.05K
Last Funding Amount
59.05K
Last Funding Date
10-09-2021
Startup Stage
Seed
Lead Investors
Commercialization Reactor
People
Founders
Karlis Udris
About
Elogium helps poultry broiler producers increase revenue and food safety by using innovative probiotic solutions
Products
Product
Probiotic poultry feed additive for Campylobacter control and broiler performance.
Star Product
PS-216 poultry probiotic, the company’s lead strain and feed-additive program.
Demo Product or Complete Product?
Pre-commercial regulatory stage, with work toward European Food Safety Authority approval.
Future Plan
Investment Funding
Secured approximately €550,000 in pre-seed funding, including investment from Commercialization Reactor Seed Fund and Biotope by VIB.
Awards and Recognitions
Participations
Developed through Commercialization Reactor and Biotope by VIB programs.
Something missing or incorrect on this page? Help us enrich this information
